LIMPRINT in specialist lymphedema services in United Kingdom, France, Italy and Turkey

Background: There is no standardized international model for specialist lymphoedema services, which covers the types of lymphoedema treated and the treatments provided. The aim of this study was to provide a profile of patients attending specialist lymphoedema services in different countries to explore similarities and differences. Methods and Results: The LIMPRINT core tool was used in specialist lymphoedema services in the UK, France, Italy and Turkey. Services in Turkey saw a slightly younger age group with a higher proportion of female patients reflecting a particular focus on breast cancer-related lymphoedema. There were higher levels of obesity and restricted mobility in patients in the UK compared with other countries. Italy and France saw the highest percentage of patients with primary lymphoedema. Diabetes was a common comorbidity in the UK and Turkey. The UK saw the largest number of patients with lower limb lymphoedema. Conclusions: The results show a wide range of complexity of patients treated in specialist lymphoedema services. Some of the differences between countries may reflect different stages in the evolution of specialist lymphoedema services, rather than a true difference in prevalence, with those with 'younger' services treating a high proportion of patients with cancer and those with more established services treating a wider range of different types of lymphoedema including more elderly people with multiple comorbidities

Life Quality Impairment Caused by Hookworm-Related Cutaneous Larva Migrans in Resource-Poor Communities in Manaus, Brazil

Hookworm-related cutaneous larva migrans (CLM) is a parasitic skin disease common in developing countries with hot climates. In resource-poor settings, CLM is associated with considerable morbidity. The disease is caused by animal hookworm larvae that penetrate the skin and migrate aimlessly in the epidermis as they cannot penetrate the basal membrane. Particularly in the rainy season, the intensity of infection is high with up to 40 larval tracks in an affected individual. Tracks are very itchy and are surrounded by a significant inflammation of the skin. Bacterial superinfection is common and intensifies the inflammation. The psychosocial consequences caused by CLM have never been investigated. We showed that CLM causes skin disease-associated life quality impairment in 91 patients with CLM. Skin disease-associated life quality was significantly impaired. The degree of impairment correlated to the intensity of infection and the number of body areas affected. After treatment with ivermectin, life quality was rapidly restored

Anaesthetic Impairment of Immune Function Is Mediated via GABAA Receptors

GABA(A) receptors are members of the Cys-loop family of neurotransmitter receptors, proteins which are responsible for fast synaptic transmission, and are the site of action of wide range of drugs. Recent work has shown that Cys-loop receptors are present on immune cells, but their physiological roles and the effects of drugs that modify their function in the innate immune system are currently unclear. We are interested in how and why anaesthetics increase infections in intensive care patients; a serious problem as more than 50% of patients with severe sepsis will die. As many anaesthetics act via GABA(A) receptors, the aim of this study was to determine if these receptors are present on immune cells, and could play a role in immunocompromising patients.We demonstrate, using RT-PCR, that monocytes express GABA(A) receptors constructed of α1, α4, β2, γ1 and/or δ subunits. Whole cell patch clamp electrophysiological studies show that GABA can activate these receptors, resulting in the opening of a chloride-selective channel; activation is inhibited by the GABA(A) receptor antagonists bicuculline and picrotoxin, but not enhanced by the positive modulator diazepam. The anaesthetic drugs propofol and thiopental, which can act via GABA(A) receptors, impaired monocyte function in classic immunological chemotaxis and phagocytosis assays, an effect reversed by bicuculline and picrotoxin.Our results show that functional GABA(A) receptors are present on monocytes with properties similar to CNS GABA(A) receptors. The functional data provide a possible explanation as to why chronic propofol and thiopental administration can increase the risk of infection in critically ill patients: their action on GABA(A) receptors inhibits normal monocyte behaviour. The data also suggest a potential solution: monocyte GABA(A) receptors are insensitive to diazepam, thus the use of benzodiazepines as an alternative anesthetising agent may be advantageous where infection is a life threatening problem

Genome of the Avirulent Human-Infective Trypanosome—Trypanosoma rangeli

Background: Trypanosoma rangeli is a hemoflagellate protozoan parasite infecting humans and other wild and domestic mammals across Central and South America. It does not cause human disease, but it can be mistaken for the etiologic agent of Chagas disease, Trypanosoma cruzi. We have sequenced the T. rangeli genome to provide new tools for elucidating the distinct and intriguing biology of this species and the key pathways related to interaction with its arthropod and mammalian hosts.  Methodology/Principal Findings: The T. rangeli haploid genome is ,24 Mb in length, and is the smallest and least repetitive trypanosomatid genome sequenced thus far. This parasite genome has shorter subtelomeric sequences compared to those of T. cruzi and T. brucei; displays intraspecific karyotype variability and lacks minichromosomes. Of the predicted 7,613 protein coding sequences, functional annotations could be determined for 2,415, while 5,043 are hypothetical proteins, some with evidence of protein expression. 7,101 genes (93%) are shared with other trypanosomatids that infect humans. An ortholog of the dcl2 gene involved in the T. brucei RNAi pathway was found in T. rangeli, but the RNAi machinery is non-functional since the other genes in this pathway are pseudogenized. T. rangeli is highly susceptible to oxidative stress, a phenotype that may be explained by a smaller number of anti-oxidant defense enzymes and heatshock proteins.  Conclusions/Significance: Phylogenetic comparison of nuclear and mitochondrial genes indicates that T. rangeli and T. cruzi are equidistant from T. brucei. In addition to revealing new aspects of trypanosome co-evolution within the vertebrate and invertebrate hosts, comparative genomic analysis with pathogenic trypanosomatids provides valuable new information that can be further explored with the aim of developing better diagnostic tools and/or therapeutic targets

Plant perception of β-aminobutyric acid is mediated by an aspartyl-tRNA synthetase

Specific chemicals can prime the plant immune system for augmented defense. β-aminobutyric acid (BABA) is a priming agent that provides broad-spectrum disease protection. However, BABA also suppresses plant growth when applied in high doses, which has hampered its application as a crop defense activator. Here we describe a mutant of Arabidopsis thaliana that is impaired in BABA-induced disease immunity (ibi1) but is hypersensitive to BABA-induced growth repression. IBI1 encodes an aspartyl-tRNA synthetase. Enantiomer-specific binding of the R enantiomer of BABA to IBI1 primed the protein for noncanonical defense signaling in the cytoplasm after pathogen attack. This priming was associated with aspartic acid accumulation and tRNA-induced phosphorylation of translation initiation factor eIF2α. However, mutation of eIF2α-phosphorylating GCN2 kinase did not affect BABA-induced immunity but relieved BABA-induced growth repression. Hence, BABA-activated IBI1 controls plant immunity and growth via separate pathways. Our results open new opportunities to separate broad-spectrum disease resistance from the associated costs on plant growth

Culture in vitro of rosewood (Aniba rosaeodora Ducke) embryos´seeds and buds explants

This study deals with the establishment in vitro of Aniba rosaeodora Ducke explants, free from fungical and endogenous contaminations and phenolic oxidation. Bud explants and embryos' seeds from many maturation stages were used in this trial. The explants were disinfected with Ampicilin antibiotic, Streptomicine Sulphate (Agrimicina), etanol (70%), sodium hipoclorite in many concentrations and exposure time acording to the type of explant. For the phenolic oxidation control, the immersion on ascorbic acid and PVP (Polyvinilpirrolidone) in culture medium were used. The explants were inoculated in MS medium. The statistical design was the completely randomized and the treatments and repetitions varied according to the type of explant adopted. After 45 days, 100% of survival and 53% of germination in embryos were observed, which had been desinfested by sodium hipoclorite (50%) for 10 minutes and inoculated in MS medium, supplemented with 20 ml of coconut water. Satisfactory results (51% of survival) were observed in bud´s explants, which had been treated by immersion in 300 mg.l-1 of Agrimicina and 25% when submitted in 500 mg.l-1 on vacuum pre-treatment.", 'enEste trabalho teve como objetivo o estabelecimento in vitro de embriões e de gemas de mudas de pau-rosa (Aniba rosaeodora Ducke) livres de contaminações e de oxidação fenólica. As gemas foram obtidas da rebrota de mudas cultivadas em viveiro e os embriões a partir de sementes em diversos estágios de maturação. Para a assepsia dos explantes foram utilizados dois antibiótico (Ampicilina e Agrimicina), etanol (70%) e hipoclorito de sódio, em concentrações e tempo de exposição variando em função do tratamento. Para o controle da oxidação foram utilizados imersão em ácido ascórbico (250 mg/l) e PVP (Polivinilpirrolidona) no meio Murashige & Skoog (MS). O delineamento estatístico empregado foi o inteiramente ao acaso com tratamentos e repetições em função do tipo de explante. Foi observado 71% de sobrevivência e 53% de germinação de embriões tratados com hipoclorito de sódio (50% e 2% de cloro ativo) por 10 minutos e inoculados em meio MS contendo 20 mg/l de água de côco após 45 dias. As gemas das rebrotas de mudas tratadas com solução de Sulfato de Estreptomicina (Agrimicina) na concentração de 500 mg/l (1h) apresentaram 51% de sobrevivência. Quando submetidas ao pré-tratamento com o emprego de bomba a vácuo (180 mmHg) contendo a Agrimicina (500 mg/l), apresentaram 25% de sobrevivência